Abbott India Q4 Profit Jumps 28% on Strong Medicine Sales and Efficiency Gains
Abbott India Q4 Profit Jumps 28% on Strong Medicine Sales and Efficiency Gains Robust demand in gastrointestinal and chronic care therapies propels Abbott India’s profit growth and revenue momentum in the March 2025 quarter. Strong Q4 Numbers Reinforce Market … Continue reading Abbott India Q4 Profit Jumps 28% on Strong Medicine Sales and Efficiency Gains
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed